Consonance Capital Management LP → Pacira BioSciences, Inc. PCRX

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 9/100

Passive Schedule 13G filer baseline
Congressional purchase disclosure (3 trades in ±90d)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

4 transactions

0 buys · 2 sales · 2 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.08

4,260,076 shares short · -47.3% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-10-08	RIKER LAUREN	officer	Option exercise	6,000	$32.35	$194K
2026-10-08	RIKER LAUREN	officer	Sale	6,000	$36.32	$218K
2026-04-23	Cross Shawn	officer	Option exercise	12,941	$16.45	$213K
2026-04-23	Cross Shawn	officer	Sale	12,941	$25.16	$326K

Other 13D/G Filings on Pacira BioSciences, Inc.

Filed	Form	Filer	Stake	Shares
2026-10-13	SCHEDULE 13D/A	Doma Perpetual Capital Management LLC	—	0	view →
2026-01-02	SCHEDULE	Doma Perpetual Capital Management LLC	6.83%	2,936,794	view →
2019-07-10	SC	Consonance Capital Management LP	—	—	view →

Other Filings by Consonance Capital Management LP

Filed	Form	Issuer	Stake	Shares
2021-09-29	SC	Surrozen, Inc./DE SRZNW	—	—	view →
2021-08-18	SC	Surrozen, Inc./DE SRZNW	—	—	view →
2021-04-27	SC	Consonance-HFW Acquisition Corp. SRZNW	—	—	view →
2019-07-10	SC	Pacira BioSciences, Inc. PCRX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →